Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Ou

Showing results (161-170 of 164) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 164 results.
Anticancer Research|March 9, 2012
Erlotinib treatment in patients with advanced lung adenocarcinoma with CISH-positive and CISH-negative EGFR gene alterationsMing-Mo Hou, Shiu-Feng Huang, Han-Pin Kuo, et al.
Molecular Oncology|June 5, 2019
Negative regulation of miR-1275 by H3K27me3 is critical for glial induction of glioblastoma cellsJialuo Mai, Jiayu Gu, Ying Liu, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 19, 2025
Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and ChallengesJames W T Yates, Michael Zientek, Kunal S Taskar, et al.
Frontiers in Immunology|February 5, 2025
A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findingsSteven P Treon, Camille N Kotton, David J Park, et al.
Pageof 17

Showing results (161-170 of 164) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 164 results.
Anticancer Research|March 9, 2012
Erlotinib treatment in patients with advanced lung adenocarcinoma with CISH-positive and CISH-negative EGFR gene alterationsMing-Mo Hou, Shiu-Feng Huang, Han-Pin Kuo, et al.
Molecular Oncology|June 5, 2019
Negative regulation of miR-1275 by H3K27me3 is critical for glial induction of glioblastoma cellsJialuo Mai, Jiayu Gu, Ying Liu, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 19, 2025
Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and ChallengesJames W T Yates, Michael Zientek, Kunal S Taskar, et al.
Frontiers in Immunology|February 5, 2025
A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findingsSteven P Treon, Camille N Kotton, David J Park, et al.
Pageof 17